PPARα regulates mobilization and homing of endothelial progenitor cells through the HIF-1α/SDF-1 pathway

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 6, 2014, Pages 3820-3832

  Wang, Zhong Xiao ^a,b   Moran, Elizabeth ^b   Ding, Lexi ^b,c   Cheng, Rui ^b   Xu, Xun ^a   Ma, Jian Xing ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Endothelial progenitor cells; Neovascularization; Oxygen induced retinopathy; PPAR ; Retina

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; FENOFIBRIC ACID; HYPOXIA INDUCIBLE FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINA ANGIOGRAPHY; RETINA NEOVASCULARIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ENDOTHELIAL PROGENITOR CELLS; NEOVASCULARIZATION; OXYGEN-INDUCED RETINOPATHY; PPARΑ; RETINA;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CEREBROVASCULAR CIRCULATION; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FENOFIBRATE; FLOW CYTOMETRY; FLUORESCEIN ANGIOGRAPHY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; HYPOLIPIDEMIC AGENTS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXYGEN; PPAR ALPHA; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; STEM CELLS;

EID: 84902665816     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13396     Document Type: Article

References (40)

1. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275:964-967.
2. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593-600.
3. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2008;28:1584-1595.
4. Patschan D, Krupincza K, Patschan S, Zhang Z, Hamby C, Goligorsky MS. Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioning. Am J Physiol Renal Physiol. 2006;291:F176-F185.
5. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res. 2004;95:343-353.
6. Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999;283:845-848.
7. Peled A, Grabovsky V, Habler L, et al. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34({thorn}) cells on vascular endothelium under shear w. J Clin Invest. 1999; 104:1199-1211.
8. Zhou X, Porter AL, Robinson DK, Shim MS, Guo Y. Nanoenabled drug delivery: A research profile [published online ahead of print March 12, 2014]. Nanomedicine. doi:10.1016/j. nano.2014.03.001.
9. Kullberg M, McCarthy R, Anchordoquy TJ. Gene delivery to Her-2{thorn} breast cancer cells using a two-component delivery system to achieve specificity [published online ahead of print March 12, 2014]. Nanomedicine doi:10.1016/j.nano.2014.03.001.
10. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10:858-864.
11. Hartnett ME, Penn JS. Mechanisms and management of retinopathy of prematurity. N Engl J Med. 2012;367:2515-2526.
12. Connor KM, Krah NM, Dennison RJ, et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc. 2009;4:1565-1573.
13. Nakagawa Y, Masuda H, Ito R, et al. Aberrant kinetics of bone marrow-derived endothelial progenitor cells in the murine oxygen-induced retinopathy model. Invest Ophthalmol Vis Sci. 2011;52:7835-7841.
14. Longeras R, Farjo K, Ihnat M, Ma JX. A PEDF-derived peptide inhibits retinal neovascularization and blocks mobilization of bone marrow-derived endothelial progenitor cells. Exp Diabetes Res. 2012;2012:5184-5226.
15. Kraja AT, Province MA, Straka RJ, Ordovas JM, Borecki IB, Arnett DK. Fenofibrate and metabolic syndrome. Endocr Metab Immune Disord Drug Targets. 2010;10:138-148.
16. Zak Z, Gelebart P, Lai R. Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha/NF-kappaB signaling axis. Leukemia. 2010;24: 1476-1486.
17. Chen Y, Hu Y, Lin M, et al. Therapeutic effects of PPARalpha agonists on diabetic retinopathy in type 1 diabetes models. Diabetes. 2013;62:261-272.
18. Benameur T, Tual-Chalot S, Andriantsitohaina R, Martinez MC. PPARalpha is essential for microparticle-induced differentiation of mouse bone marrow-derived endothelial progenitor cells and angiogenesis. PLoS One. 2010;5:e12392.
19. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35: 101-111.
20. Chen Y, Hu Y, Zhou T, et al. Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. Am J Pathol. 2009;175:2676-2685.
21. Lin CD, Kou YY, Liao CY, et al. Zinc oxide nanoparticles impair bacterial clearance by macrophages [published online ahead of print March 17, 2014]. Nanomedicine (Lond). doi:10.2217/ nnm.14.48.
22. Wu Z, Hofman FM, Zlokovic BV. A simple method for isolation and characterization of mouse brain microvascular endothelial cells. J Neurosci Methods. 2003;130:53-63.
23. Kelly BD, Hackett SF, Hirota K, et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res. 2003;93:1074-1081.
24. Zhou J, Zhang S, Xue J, et al. Activation of peroxisome proliferator-activated receptor alpha (PPARalpha) suppresses hypoxia-inducible factor-1alpha (HIF-1alpha) signaling in cancer cells. J Biol Chem. 2012;287:35161-35169.
25. Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia. 2006;20:1915-1924.
26. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267: 10931-10934.
27. Fazel S, Cimini M, Chen L, et al. Cardioprotective c-kit{thorn} cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest. 2006;116: 1865-1877.
28. Tsutsumi H, Tanaka T, Ohashi N, et al. Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents. Biopolymers. 2007;88:279-289.
29. Machalinska A, Modrzejewska M, Kotowski M, et al. Circulating stem cell populations in preterm infants: implications for the development of retinopathy of prematurity. Arch Ophthalmol. 2010;128:1311-1319.
30. Hiukka A, Maranghi M, Matikainen N, Taskinen MR. PPARalpha: an emerging therapeutic target in diabetic microvascular damage. Nat Rev Endocrinol. 2010;6:454-463.
31. Keech AC, Mitchell P, Summanen PA, et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet. 2007;370:1687-1697.
32. Accord Study Group, Accord Eye Study Group, Chew EY, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010;363:233-244.
33. Yang X, Downes M, Yu RT, et al. Nuclear receptor expression links the circadian clock to metabolism. Cell. 2006;126:801-810.
34. Busik JV, Tikhonenko M, Bhatwadekar A, et al. Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J Exp Med. 2009;206:2897-2906.
35. Hattori K, Heissig B, Tashiro K, et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood. 2001;97:3354-3360.
36. De Falco E, Porcelli D, Torella AR, et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood. 2004;104:3472-3482.
37. Ross JS, Hu W, Rosen B, Snider AJ, Obeid LM, Cowart LA. Sphingosine kinase 1 is regulated by peroxisome proliferatoractivated receptor alpha in response to free fatty acids and is essential for skeletal muscle interleukin-6 production and signaling in diet-induced obesity. J Biol Chem. 2013;288: 22193-22206.
38. Walter DH, Rochwalsky U, Reinhold J, et al. Sphingosine-1- phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor. Arterioscler Thromb Vasc Biol. 2007; 27:275-282.
39. Cisneros BT, Law JJ, Matson ML, Azhdarinia A, Sevick-Muraca EM, Wilson LJ. Stable confinement of positron emission tomography and magnetic resonance agents within carbon nanotubes for bimodal imaging [published online ahead of print March 17, 2014]. Nanomedicine (Lond). doi:10.2217/ nnm.14.26.
40. Bartneck M, Peters FM, Warzecha KT, et al. Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages [published online ahead of print March 7, 2014]. Nanomedicine. doi:10.1016/j.nano.2014.02.011.